Female sexual dysfunction (FSD): Prevalence and impact on quality of life (QoL).
Rossella E Nappi, Laura Cucinella, Silvia Martella...
https://pubmed.ncbi.nlm.nih.gov/27823751/Actively Recruiting
Led by Centre Oscar Lambret · Updated on 2026-03-18
75
Participants Needed
1
Research Sites
N/A
Total Duration
Researchers are studying whether vaginal radiofrequency therapy can help reduce vaginal dryness in women undergoing hormonal treatment for breast cancer. This Phase III trial compares vaginal radiofrequency combined with a non-hormonal vaginal moisturizer to the moisturizer alone. Participants are women over 40 years old receiving aromatase inhibitors, with or without LHRH agonists, as part of their breast cancer treatment. Participants are randomly assigned to one of two groups. One group will use a hyaluronic acid-based vaginal moisturizer three times a week, with optional supportive treatments like physiotherapy or vaginal dilators. The other group receives the same moisturizer treatment plus three sessions of vaginal radiofrequency therapy spaced 4 to 6 weeks apart. A possible maintenance radiofrequency session may occur between 8 and 12 months after the first session. During participation, women will have clinical evaluations at baseline, 3, 6, and 12 months to assess vaginal dryness and related symptoms. Researchers will measure vaginal dryness severity using a numerical scale, as well as vaginal health indicators such as elasticity, fluid volume, pH, epithelial integrity, and moisture. Safety and side effects of the radiofrequency treatment will also be monitored through 12 months.
CONDITIONS
Efficacy and Safety of Vaginal Radiofrequency for Vulvovaginal Atrophy in Breast Cancer Patients
F
Fanny BEN OUNE
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Centre Oscar Lambret
Lead Sponsor
MATMATECH
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 6 months
Participants receive local hydration treatment with a hyaluronic acid-based moisturizer applied three times a week. Those in the experimental group also receive three sessions of vaginal radiofrequency therapy spaced 4 to 6 weeks apart, with an optional maintenance session between 8 and 12 months after the first session.
3 radiofrequency therapy sessions plus regular moisturizer usage; clinical evaluation visits at baseline, 3 months, and 6 months
Duration - Up to 12 months
Participants are monitored for safety and efficacy outcomes up to 12 months after starting treatment, including an optional maintenance radiofrequency session for the experimental group and clinical evaluations.
Clinical evaluation visits at 12 months, plus possible maintenance therapy session between months 8 and 12
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Rossella E Nappi, Laura Cucinella, Silvia Martella...
https://pubmed.ncbi.nlm.nih.gov/27823751/Ayane Cristine Alves Sarmento, Fabíola S Fernandes, Ana Paula Ferreira Costa...
https://pubmed.ncbi.nlm.nih.gov/34226218/Nicoletta Biglia, Valentina E Bounous, Luca G Sgro...
https://pubmed.ncbi.nlm.nih.gov/26198332/Santiago Palacios, Camil Castelo-Branco, Heather Currie...
https://pubmed.ncbi.nlm.nih.gov/26261035/Maurizio Filippini, Irene Porcari, Alessandro F Ruffolo...
https://pubmed.ncbi.nlm.nih.gov/35101378/Eva von Schoultz, Lars E Rutqvist, Stockholm Breast Cancer Study Group
https://pubmed.ncbi.nlm.nih.gov/15812079/Stephanie S Faubion, Richa Sood, Ekta Kapoor
https://pubmed.ncbi.nlm.nih.gov/29202940/Elisabeth Sulaica, Tiffany Han, Weiqun Wang...
https://pubmed.ncbi.nlm.nih.gov/27178335/M Di Maio, E Basch, F Denis...
https://pubmed.ncbi.nlm.nih.gov/35462007/P T Juliato, A T Rodrigues, R Stahlschmidt...
https://pubmed.ncbi.nlm.nih.gov/27876429/Centre Oscar Lambret
Lead Sponsor
MATMATECH
Collaborating Sponsor